Receptor Action of Antihistamines
Antihistamines primarily act as inverse agonists at histamine receptors, binding to H1 receptors to inhibit histamine-induced inflammation and block the effects of histamine on target tissues. 1
Mechanism of Action
H1 Receptor Antagonism:
- Antihistamines competitively bind to H1 receptors, preventing histamine from activating these receptors
- They function as inverse agonists rather than simple antagonists, stabilizing the receptor in an inactive conformation 1
- This action blocks both neural and vascular H1 receptors, reducing symptoms such as nasal itching, sneezing, and rhinorrhea 2
Receptor Distribution and Effects:
- H1 receptors are widely distributed throughout the body, particularly in:
- Nasal trigeminal nerve fibers (mediating itch and sneezing)
- Nasal endothelial cells (affecting plasma extravasation and edema)
- Smooth muscle cells (affecting contraction)
- Activation of H1 receptors on nasal trigeminal nerve fibers transmits nasal itch and triggers sneezing 3
- H1 receptor activation on endothelial cells causes contraction, leading to plasma extravasation and edema formation 3
- H1 receptors are widely distributed throughout the body, particularly in:
Additional Receptor Types:
First vs. Second Generation Antihistamines
First-Generation Antihistamines:
- Have significant anticholinergic effects and CNS penetration
- Examples include diphenhydramine 5 and chlorpheniramine
- More effective in suppressing URI-induced cough than second-generation antihistamines due to:
- Greater anticholinergic activity
- Central penetration affecting H1 histaminergic and/or M1 muscarinic receptors in the CNS 4
- Associated with sedation and cognitive decline, particularly in elderly patients 4
Second-Generation Antihistamines:
- Higher specificity and affinity for peripheral H1 receptors
- Examples include loratadine 6, cetirizine, and fexofenadine
- Less sedating due to reduced CNS penetration 7
- Longer duration of action but similar onset of action compared to first-generation agents 4
- Often used at 2-4 times FDA-approved doses in conditions like mast cell activation syndrome 4
Pharmacokinetics and Clinical Effects
Onset and Duration:
- Oral antihistamines are rapidly absorbed but may take 30-60 minutes for onset of action
- Peak plasma concentrations occur at 60-120 minutes
- Additional 60-90 minutes may be needed for diffusion into extravascular tissues for maximal effect 4
- Second-generation antihistamines typically provide 24-hour symptom relief, allowing once-daily dosing 3
Clinical Effects:
- Most effective for symptoms like itching, sneezing, and rhinorrhea
- Less effective for nasal congestion/blockage (both H1 and H2 antihistamines have weak effects) 8
- Reduce proinflammatory effects mediated by H1 receptors
- Improve physical and mental performance by reducing allergy-related activity impairment 3
Important Clinical Considerations
Limitations in Acute Reactions:
Safety Considerations:
- First-generation antihistamines should be avoided in elderly patients due to increased risk of falls, cognitive impairment, and anticholinergic effects 9
- Second-generation antihistamines are generally safe with minimal adverse effects 3
- No evidence of tachyphylaxis, tolerance, or rebound with modern antihistamines 3
Combination Therapy:
Understanding the receptor action of antihistamines is crucial for appropriate clinical use and maximizing therapeutic benefits while minimizing adverse effects.